Valiant Organics Ltd
Valiant Organics Ltd Q1 FY25 Results & Presentation Highlights: Revenue, Margins & Order Book
Q1 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on Valiant Organics Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q1-FY25 Revenue from Operations: INR 1,679 Mn - Year-on-Year Revenue Change: - Standalone: Decreased 4.9% from INR 1,766 Mn in Q1-FY24 (Page 13) - Consolidated: Decreased 16.8% from INR 2,018 Mn in Q1-FY24 (Page 12) - Sales Volumes (MT) by Key Chemistries (Q1-FY25 vs Q1-FY24): - Chlorination: 660 MT vs 697 MT - Hydrogenation: 543 MT vs 475 MT - Ammonolysis: 118 MT vs 127 MT - Others: 333 MT vs 271 MT (Page 11) - Explicit Outlook: - Demand in dyes and pigments industry has improved with optimism for agrochemicals and pharmaceuticals sectors to increase demand soon. Q1-FY25 Consolidated EBITDA: INR 157 Mn, down 34.3% YoY (from INR 239 Mn in Q1-FY24) - Q1-FY25 Consolidated EBITDA Margin: 9.35%, down 249 bps YoY (from 11.84% in Q1-FY24) - Q1-FY25 Consolidated P
From Valiant Organics Ltd's Q1 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1-FY25 Revenue from Operations: INR 1,679 Mn
- Year-on-Year Revenue Change:
- Standalone: Decreased 4.9% from INR 1,766 Mn in Q1-FY24 (Page 13)
- Consolidated: Decreased 16.8% from INR 2,018 Mn in Q1-FY24 (Page 12)
- Sales Volumes (MT) by Key Chemistries (Q1-FY25 vs Q1-FY24):
- Chlorination: 660 MT vs 697 MT
- Hydrogenation: 543 MT vs 475 MT
- Ammonolysis: 118 MT vs 127 MT
- Others: 333 MT vs 271 MT (Page 11)
- Explicit Outlook:
2 more points management made on revenue & sales performance
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Valiant Organics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹218 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics Ltd's management said in earlier quarters
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q1 FY23 earnings call →
- Q4 FY22 earnings call →
Others in Chemicals & Petrochemicals this season
- Himadri Speciality Chemical Ltd (Q1 FY25)
1,199.77 Cr, up 26.17% YoY (vs Rs. Key investor presentation takeaways from Himadri Speciality Chemical Ltd's Q1 FY25 investor presentation — and how it ranks a
- Balaji Amines Ltd (Q1 FY25)
Q1FY25 consolidated revenue from operations: ₹393 crore, down 16% YoY from ₹469 crore in Q1FY24 (Page 5 & 6). Key investor presentation takeaways from Balaji Am
- Linde India Ltd (Q1 FY25)
Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. Key investor presentation takeaways from Linde India Ltd's Q1 FY25 investor presentation — and ho
- Vidhi Specialty Food Ingredients Ltd (Q1 FY25)
83.0 Crs, up 4.1% year-on-year from Rs. Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY25 investor presentation — and how
Frequently Asked Questions
What were Valiant Organics Ltd Q1 FY25 results?
Q1-FY25 Revenue from Operations: INR 1,679 Mn - Year-on-Year Revenue Change: - Standalone: Decreased 4.9% from INR 1,766 Mn in Q1-FY24 (Page 13) - Consolidated: Decreased 16.8% from INR 2,018 Mn in Q1-FY24 (Page 12) - Sales Volumes (MT) by Key Chemistries (Q1-FY25 vs Q1-FY24): - Chlorination: 660 MT vs 697 MT - Hydrogenation: 543 MT vs 475 MT - Ammonolysis: 118 MT vs 127 MT - Others: 333 MT vs 271 MT (Page 11) - Explicit Outlook: - Demand in dyes and pigments industry has improved with optimism for agrochemicals and pharmaceuticals sectors to increase demand soon. Q1-FY25 Consolidated EBITDA: INR 157 Mn, down 34.3% YoY (from INR 239 Mn in Q1-FY24) - Q1-FY25 Consolidated EBITDA Margin: 9.35%, down 249 bps YoY (from 11.84% in Q1-FY24) - Q1-FY25 Consolidated P
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Is Valiant Organics Ltd planning capital expenditure?
The presentation does not explicitly mention any ongoing or planned capex, capacity expansions, new plants, or projects with associated amounts, status, or timelines.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.